APA

Schildcrout J. S., Denny J. C., Bowton E., Gregg W., Pulley J. M., Basford M. A., Cowan J. D., Xu H., Ramirez A. H., Crawford D. C., Ritchie M. D., Peterson J. F., Masys D. R., Wilke R. A. & Roden D. M. (20121018). Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping. : Clinical pharmacology and therapeutics.

Chicago

Schildcrout J S, Denny J C, Bowton E, Gregg W, Pulley J M, Basford M A, Cowan J D, Xu H, Ramirez A H, Crawford D C, Ritchie M D, Peterson J F, Masys D R, Wilke R A and Roden D M. 20121018. Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping. : Clinical pharmacology and therapeutics.

Harvard

Schildcrout J. S., Denny J. C., Bowton E., Gregg W., Pulley J. M., Basford M. A., Cowan J. D., Xu H., Ramirez A. H., Crawford D. C., Ritchie M. D., Peterson J. F., Masys D. R., Wilke R. A. and Roden D. M. (20121018). Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping. : Clinical pharmacology and therapeutics.

MLA

Schildcrout J S, Denny J C, Bowton E, Gregg W, Pulley J M, Basford M A, Cowan J D, Xu H, Ramirez A H, Crawford D C, Ritchie M D, Peterson J F, Masys D R, Wilke R A and Roden D M. Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping. : Clinical pharmacology and therapeutics. 20121018.